Leipzig University, in Leipzig in the Free State of Saxony, Germany, is one of the world's oldest universities and the second-oldest university in Germany.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Fred Hutchinson Cancer Center
12
University of Leipzig
12
Boston Scientific Corporation
3
Celgene
3
Gilead Sciences
3
C. R. Bard
2
Rhythm Pharmaceuticals, Inc.
2
AGC Biologics S.p.A.
1
AO Clinical Investigation and Publishing Documentation
1
Abbott Medical Devices
1
Acacia Pharma Ltd
1
Clinical Trials at University of Leipzig
During the past decade, University of Leipzig conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 17 clinical trials were completed, i.e. on
average, 45.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
2001-08-01
2004-09-05
Completed
106
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Leipzig" #1 sponsor was "Fred Hutchinson Cancer Center" with 12 trials, followed by "University of Leipzig" with 12 trials
sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Celgene" with 3 trials sponsored and "Gilead Sciences"
with 3 trials sponsored. Other sponsors include 55 different institutions and
companies that sponsored additional 63 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Leipzig"
#1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "University of Leipzig" with 4 trials as a collaborator, "European Society of Anaesthesiology" with 3 trials as a collaborator and "German Research Foundation" with 2 trials as a collaborator. Other collaborators include 67 different institutions and companies that were
collaborators in the rest 75 trials.
Clinical Trials Conditions at University of Leipzig
According to Clinical.Site data, the most researched conditions in "University of Leipzig" are
"Refractory Chronic Lymphocytic Leukemia" (9 trials), "Recurrent Adult Acute Lymphoblastic Leukemia" (7 trials), "Recurrent Adult Acute Myeloid Leukemia" (6 trials), "Recurrent Adult Hodgkin Lymphoma" (6 trials) and "Recurrent Small Lymphocytic Lymphoma" (6 trials). Many other conditions were trialed in "University of Leipzig" in a lesser frequency.
Clinical Trials Intervention Types at University of Leipzig
Most popular intervention types in "University of Leipzig" are "Drug" (41 trials), "Procedure" (28 trials), "Other" (17 trials), "Device" (15 trials) and "Radiation" (14 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Fludarabine Phosphate" (6 trials), "Mycophenolate Mofetil" (6 trials), "Peripheral Blood Stem Cell Transplantation" (6 trials) and "Total-Body Irradiation" (6 trials). Other intervention names were less common.
Clinical Trials Genders at University of Leipzig
The vast majority of trials in "University of Leipzig" are
89 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at University of Leipzig
Currently, there are NaN active trials in "University of Leipzig".
undefined are not yet recruiting,
12 are recruiting,
7 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 56 completed trials in University of Leipzig,
1 suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in University of Leipzig, 10 "Phase 1"
clinical trials were conducted, 20 "Phase 2" clinical
trials and 22 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 30 trials that are defined as “Not Applicable".